[1]
Şener, M.U., Çiçek, T. and Öztürk, A. 2022. Highlights of clinical and laboratory parameters among severe COVID-19 patients treated with tocilizumab: a retrospective observational study. São Paulo Medical Journal. 140, 5 (Sep. 2022), 627–635.